Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), announced today that the Company and Dr. Raza Bokhari, ...

In the field of public health, the COVID-19 pandemic has highlighted significant gaps in global emergency response systems, especially evident during the ...

On May 22, 2025, the FDA approved Bio-Thera Solutions and Hikma Pharmaceuticals’ ustekinumab biosimilar, STARJEMZA® (ustekinumab-hmny) ...

Nanomedicines, especially those based on nanoparticles, are revolutionizing health care in terms of both diagnostics and ...

As a court ruling interrupts President Donald Trump’s tariff plans, the U.S.-Europe trade relationship continues to chafe ...

The FDA designates 2 biosimilars as interchangeable, enhancing access to treatments for inflammatory diseases and multiple ...

Drug pricing and reimbursement constraints are a major concern for the pharmaceutical industry. In order to balance ...

Teva outlines acceleration path into a leading biopharma companyInnovative medicines franchise on track to exceed $5 billion by 2030, led by AUSTEDO® (deutetrabenazine), AJOVY® (fremanezumab), UZEDY® ...

Holidaymakers who find themselves needing visit a pharmacy in Tenerife have been told to be careful where they actually end ...

In this era of escalating trade tensions and geopolitical uncertainty, the U.S. cannot afford to cede another critical ...